Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
NovoCure Ltd (NVCR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Medical Instruments & Supplies
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
Leonard Frank X
EVP, Pres., Novocure Oncology, Officer
NovoCure Ltd
(NVCR)
160,098
-1%
2,519
$16.02
$40,357.56
SELL
1 Mar 2024
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
251,235
-1%
3,324
$16.02
$53,252.84
SELL
27 Feb 2024
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
254,559
-0%
2,303
$16.14
$37,176.87
SELL
27 Feb 2024
Leonard Frank X
EVP, Pres., Novocure Oncology, Officer
NovoCure Ltd
(NVCR)
162,617
-1%
2,078
$16.14
$33,544.74
SELL
7 Nov 2023
Shah Pritesh
Chief Growth Officer, Officer
NovoCure Ltd
(NVCR)
124,511
-0%
382
$12.65
$4,832.30
SELL
1 Sep 2023
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
99,650
-0%
883
$21.82
$19,264.59
SELL
1 Sep 2023
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
209,825
-0%
294
$21.82
$6,414.26
SELL
1 Sep 2023
Shah Pritesh
Chief Growth Officer, Officer
NovoCure Ltd
(NVCR)
124,893
-0%
273
$21.82
$5,956.10
SELL
2 Aug 2023
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
100,533
-1%
1,144
$30.25
$34,607.26
SELL
2 Mar 2023
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
59,296
-6%
4,107
$75.38
$309,577.72
SELL
2 Mar 2023
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
67,893
-4%
2,903
$76.95
$223,393.45
SELL
2 Mar 2023
Shah Pritesh
Chief Growth Officer, Officer
NovoCure Ltd
(NVCR)
99,038
-0%
937
$75.28
$70,535.39
SELL
2 Mar 2023
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
183,402
-0%
1,213
$75.28
$91,312.09
SELL
2 Mar 2023
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
95,007
-1%
1,055
$75.28
$79,418.19
SELL
2 Mar 2023
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
66,683
-0%
281
$75.28
$21,153.09
SELL
28 Feb 2023
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
184,615
-1%
2,164
$76.36
$165,248.22
SELL
28 Feb 2023
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
66,964
-1%
755
$76.36
$57,653.61
SELL
28 Feb 2023
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
96,062
-2%
2,198
$76.36
$167,844.55
SELL
28 Feb 2023
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
63,095
-2%
1,684
$76.36
$128,594.27
SELL
28 Feb 2023
Shah Pritesh
Chief Growth Officer, Officer
NovoCure Ltd
(NVCR)
99,975
-1%
1,923
$76.36
$146,844.89
SELL
5 Jan 2023
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
30,214
-87%
212,500
$108.74
$23,106,230.00
SELL
5 Jan 2023
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
82,843
-0%
387
$108.00
$41,796.00
SELL
5 Jan 2023
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
48,111
-45%
39,507
$112.25
$4,434,654.00
SELL
5 Jan 2023
Weinberg Uri
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
47,104
-14%
8,143
$116.14
$945,756.00
SELL
13 Oct 2022
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
43,626
-13%
6,754
$76.01
$513,371.56
SELL
6 Oct 2022
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
50,380
-11%
6,754
$84.37
$569,835.00
SELL
22 Sep 2022
Leonard Frank X
President, CNS Cancers US, Officer
NovoCure Ltd
(NVCR)
63,888
-9%
6,754
$77.00
$520,058.00
SELL
15 Sep 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
76,159
-13%
12,271
$88.52
$1,086,221.80
SELL
9 Sep 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
84,150
-2%
1,863
$88.00
$163,944.00
SELL
8 Sep 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
77,396
-8%
6,754
$81.48
$550,315.94
SELL
6 Sep 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
86,013
-1%
1,384
$78.57
$108,740.88
SELL
2 Sep 2022
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
55,486
-1%
718
$79.04
$56,748.57
SELL
2 Sep 2022
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
72,376
-1%
885
$79.04
$69,947.75
SELL
2 Sep 2022
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
165,024
-0%
296
$79.04
$23,394.95
SELL
2 Sep 2022
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
83,230
-0%
269
$79.04
$21,260.95
SELL
1 Sep 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
87,397
-14%
14,796
$77.50
$1,146,633.90
SELL
3 Aug 2022
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
34,068
-14%
5,959
$73.73
$439,327.66
SELL
2 Aug 2022
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
551,176
-0%
837
$69.66
$58,304.58
SELL
2 Aug 2022
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
34,631
-1%
437
$69.66
$30,440.98
SELL
2 Aug 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
102,193
-0%
414
$69.66
$28,838.82
SELL
10 Jun 2022
HILLEMAN JERYL L
Director
NovoCure Ltd
(NVCR)
2,537
-13%
407
$69.61
$28,331.27
SELL
10 May 2022
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
34,846
-10%
4,205
$63.17
$265,645.80
SELL
8 Mar 2022
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
60,848
-1%
759
$70.10
$53,205.90
SELL
8 Mar 2022
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
165,102
-1%
2,923
$70.10
$204,902.30
SELL
8 Mar 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
102,295
-0%
744
$70.10
$52,154.40
SELL
8 Mar 2022
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
62,462
-3%
2,339
$70.10
$163,963.89
SELL
8 Mar 2022
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
552,013
-0%
2,385
$70.10
$167,188.50
SELL
8 Mar 2022
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
55,991
-1%
1,037
$70.10
$72,693.70
SELL
7 Mar 2022
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
81,908
-8%
7,775
$69.73
$542,115.80
SELL
3 Mar 2022
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
91,597
-5%
5,543
$72.54
$402,064.38
SELL
3 Mar 2022
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
61,607
-2%
1,705
$73.16
$124,744.49
SELL
3 Mar 2022
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
168,025
-2%
3,870
$71.78
$277,797.47
SELL
3 Mar 2022
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
103,039
-1%
1,485
$72.97
$108,359.02
SELL
3 Mar 2022
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
64,801
-4%
3,067
$71.87
$220,413.81
SELL
3 Mar 2022
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
57,028
-2%
1,367
$71.43
$97,641.40
SELL
3 Mar 2022
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
43,257
-5%
2,313
$71.83
$166,136.47
SELL
3 Jan 2022
Burke William Patrick
Chief Human Resources Officer, Officer
NovoCure Ltd
(NVCR)
41,036
-8%
3,951
$76.00
$300,262.60
BUY
26 Nov 2021
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
12,172
+69%
4,974
$102.44
$509,539.20
SELL
2 Nov 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
41,758
-0%
209
$107.28
$22,420.68
SELL
2 Sep 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
73,692
-0%
657
$138.57
$91,040.93
SELL
2 Sep 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
41,967
-1%
828
$138.23
$114,456.09
SELL
2 Sep 2021
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
149,899
-0%
181
$138.23
$25,019.99
SELL
2 Sep 2021
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
87,153
-0%
540
$138.23
$74,645.27
SELL
12 Aug 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
45,993
-36%
26,624
$140.94
$3,752,286.00
SELL
5 Aug 2021
Madden Martin J.
Director
NovoCure Ltd
(NVCR)
384
-8%
34
$153.13
$5,206.42
SELL
5 Aug 2021
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,859
-1%
1,000
$152.50
$152,500.00
SELL
4 Aug 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
74,169
-2%
2,063
$148.71
$306,788.75
SELL
3 Aug 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
76,232
-2%
1,654
$149.43
$247,157.20
SELL
3 Aug 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
28,144
-1%
464
$150.11
$69,651.04
SELL
2 Aug 2021
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
89,158
-1%
1,041
$149.39
$155,519.56
SELL
2 Aug 2021
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
554,398
-0%
995
$149.38
$148,631.11
SELL
31 Jul 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
83,187
-4%
3,669
$71.19
$261,196.12
SELL
30 Jul 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
28,608
-3%
1,187
$154.63
$183,549.56
SELL
6 Jul 2021
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,859
-1%
1,000
$183.54
$183,540.00
BUY
2 Jul 2021
Marie Newman
Congressman (House)
NovoCure Ltd
(NVCR)
N/A
N/A
N/A
$15,001 - 50,000
SELL
10 Jun 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
77,732
-23%
23,540
$215.00
$5,061,100.00
SELL
7 Jun 2021
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-1%
1,000
$204.55
$204,550.00
SELL
27 May 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
29,054
-5%
1,833
$200.00
$366,600.00
SELL
12 May 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
29,054
-6%
1,943
$180.48
$350,672.62
SELL
10 May 2021
Weinberg Uri
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
33,471
-14%
5,650
$189.65
$1,071,522.50
SELL
10 May 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
30,997
-11%
4,095
$184.38
$755,055.40
SELL
5 May 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
101,272
-1%
1,290
$199.67
$257,574.30
SELL
5 May 2021
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-1%
1,000
$199.67
$199,670.00
SELL
3 May 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
102,562
-1%
1,043
$200.86
$209,492.81
SELL
13 Apr 2021
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
648,993
-12%
95,000
$199.55
$18,957,448.00
SELL
13 Apr 2021
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
8,184
-92%
97,973
$196.34
$19,236,322.00
SELL
13 Apr 2021
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
74,545
-7%
6,000
$198.84
$1,193,035.00
SELL
13 Apr 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
33,259
-15%
5,958
$200.00
$1,191,600.00
SELL
31 Mar 2021
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
650,393
-1%
7,928
$134.12
$1,063,303.40
SELL
23 Mar 2021
Weinberg Uri
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
36,306
-9%
3,892
$140.00
$544,880.00
SELL
8 Mar 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
101,272
-5%
6,151
$130.97
$805,588.50
SELL
8 Mar 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
35,893
-2%
765
$130.81
$100,066.59
SELL
8 Mar 2021
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
153,684
-1%
3,004
$130.81
$392,941.22
SELL
8 Mar 2021
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
90,045
-0%
765
$130.81
$100,066.59
SELL
8 Mar 2021
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
67,714
-3%
2,404
$130.81
$314,457.62
SELL
5 Mar 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
107,423
-4%
4,550
$131.53
$598,461.50
SELL
5 Mar 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
33,259
-8%
2,918
$131.53
$383,804.53
SELL
4 Mar 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,568
-1%
567
$137.55
$77,993.12
SELL
4 Mar 2021
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
156,688
-2%
3,854
$137.55
$530,133.10
SELL
4 Mar 2021
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
90,810
-0%
567
$137.55
$77,993.12
SELL
4 Mar 2021
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
70,118
-4%
3,084
$137.55
$424,216.53
SELL
3 Mar 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
97,986
-4%
4,832
$143.50
$693,414.25
SELL
3 Mar 2021
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
36,177
-12%
5,363
$146.12
$783,662.44
SELL
2 Mar 2021
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
91,932
-0%
912
$152.05
$138,672.33
SELL
2 Mar 2021
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
27,249
-1%
428
$152.05
$65,078.68
SELL
2 Mar 2021
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
148,023
-1%
2,392
$152.05
$363,710.75
SELL
2 Mar 2021
Leonard Frank X
Chief Development Officer, Officer
NovoCure Ltd
(NVCR)
82,668
-0%
430
$152.05
$65,382.79
SELL
2 Mar 2021
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
62,860
-3%
2,355
$152.05
$358,084.80
SELL
22 Feb 2021
Weinberg Uri
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
27,597
-19%
6,500
$175.50
$1,140,750.00
SELL
15 Jan 2021
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
120,975
-34%
63,814
$172.48
$11,006,646.00
SELL
21 Dec 2020
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
29,356
-7%
2,484
$156.71
$389,267.66
SELL
18 Dec 2020
HILLEMAN JERYL L
Director
NovoCure Ltd
(NVCR)
3,400
-42%
2,500
$166.40
$416,000.00
SELL
18 Dec 2020
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
279,975
-42%
207,910
$157.39
$32,722,766.00
SELL
2 Nov 2020
Cordova Ashley
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
26,212
-0%
230
$117.41
$27,004.53
SELL
25 Sep 2020
Weinberg Uri
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
27,597
-35%
15,250
$103.35
$1,576,087.50
SELL
18 Sep 2020
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
150,669
-5%
8,262
$109.21
$902,293.70
SELL
16 Sep 2020
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
154,807
-18%
34,512
$107.81
$3,720,569.80
SELL
15 Sep 2020
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
197,632
-34%
103,000
$99.00
$10,197,000.00
SELL
14 Sep 2020
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
154,007
-33%
75,868
$101.53
$7,703,230.50
SELL
14 Sep 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-21%
19,565
$97.44
$1,906,500.00
SELL
9 Sep 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
71,165
-28%
28,321
$85.41
$2,418,880.50
SELL
9 Sep 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-20%
19,114
$87.80
$1,678,293.50
SELL
2 Sep 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-0%
100
$85.00
$8,500.00
SELL
1 Sep 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
98,786
-4%
4,200
$85.01
$357,054.20
SELL
25 Aug 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-8%
7,112
$80.13
$569,891.60
SELL
3 Aug 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
101,018
-3%
3,717
$76.63
$284,828.50
SELL
3 Aug 2020
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
29,356
-2%
660
$76.06
$50,199.60
SELL
31 Jul 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
649,062
-0%
896
$76.39
$68,443.65
SELL
30 Jul 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
72,045
-8%
7,112
$75.00
$533,400.00
SELL
21 Jul 2020
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
228,893
-16%
46,293
$66.88
$3,096,038.20
SELL
21 Jul 2020
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
81,122
-10%
10,000
$66.93
$669,333.60
SELL
7 Jul 2020
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
30,016
-1%
341
$76.39
$26,048.31
SELL
12 May 2020
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
12,616
-17%
2,595
$64.78
$168,104.10
SELL
11 May 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
649,958
-4%
31,332
$63.73
$1,996,725.80
SELL
8 May 2020
Benaim Ely
Chief Medical Officer, Officer
NovoCure Ltd
(NVCR)
15,211
-9%
1,611
$63.73
$102,665.81
SELL
7 May 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
681,290
-8%
62,896
$64.11
$4,032,390.00
SELL
5 May 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
100,693
-1%
1,149
$62.20
$71,467.81
SELL
5 May 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
567,883
-9%
60,164
$63.36
$3,812,170.00
SELL
1 May 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
101,842
-1%
1,184
$60.08
$71,133.53
SELL
13 Apr 2020
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
221,244
-20%
58,500
$70.11
$4,101,564.50
SELL
6 Mar 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
86,438
-6%
6,151
$66.76
$410,621.94
SELL
6 Mar 2020
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
140,386
-2%
3,123
$69.53
$217,154.67
SELL
6 Mar 2020
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
86,753
-2%
2,499
$69.53
$173,765.45
SELL
6 Mar 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
510,511
-0%
4,320
$69.53
$300,386.88
SELL
6 Mar 2020
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
220,867
-1%
2,274
$69.53
$158,120.31
SELL
2 Mar 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
67,721
-2%
1,485
$72.97
$108,360.45
SELL
28 Feb 2020
GROENHUYSEN WILHELMUS CM
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
150,014
-2%
3,670
$72.22
$265,029.03
SELL
27 Feb 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
69,206
-2%
1,601
$72.22
$115,616.21
SELL
27 Feb 2020
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
70,032
-3%
2,643
$72.22
$190,864.23
SELL
27 Feb 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
514,831
-0%
3,893
$72.22
$281,132.97
SELL
27 Feb 2020
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
208,726
-1%
2,673
$72.22
$193,030.69
SELL
25 Feb 2020
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
73,553
-15%
12,999
$80.08
$1,040,942.80
SELL
24 Feb 2020
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
111,768
-14%
18,908
$81.16
$1,534,497.60
SELL
24 Feb 2020
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
67,119
-11%
8,482
$81.16
$688,365.20
SELL
24 Feb 2020
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
205,226
-5%
11,647
$81.16
$945,223.94
SELL
22 Jan 2020
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
87,343
-3%
2,915
$98.14
$286,084.12
SELL
17 Jan 2020
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
509,465
-20%
133,777
$95.00
$12,708,815.00
SELL
2 Dec 2019
PHILLIPS CHARLES G III
Director
NovoCure Ltd
(NVCR)
3,359
-64%
6,145
$88.11
$541,448.25
SELL
25 Nov 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
643,242
-2%
16,223
$96.04
$1,558,056.90
SELL
25 Nov 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
134,601
-43%
103,000
$95.00
$9,785,000.00
SELL
25 Nov 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-22%
20,000
$95.00
$1,900,000.00
SELL
20 Nov 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
660,165
-18%
150,000
$90.36
$13,553,724.00
SELL
20 Nov 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-22%
20,000
$90.00
$1,800,000.00
SELL
15 Nov 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
91,211
-22%
25,832
$83.87
$2,166,563.20
SELL
15 Nov 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-22%
20,000
$84.12
$1,682,353.80
SELL
13 Nov 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
91,748
-42%
67,576
$81.28
$5,492,306.00
SELL
11 Nov 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
87,179
-35%
48,600
$80.16
$3,895,924.50
SELL
11 Nov 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
811,565
-5%
43,000
$80.59
$3,465,392.20
SELL
11 Nov 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-6%
5,000
$79.57
$397,850.00
SELL
4 Nov 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,674
-30%
80,819
$79.00
$6,384,701.00
SELL
10 Oct 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-6%
5,000
$72.28
$361,400.00
SELL
24 Sep 2019
GROENHUYSEN WILHELMUS CM
CFO, Officer
NovoCure Ltd
(NVCR)
87,479
-8%
7,992
$80.63
$644,398.00
SELL
13 Sep 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
109,479
-31%
50,000
$79.38
$3,968,881.50
SELL
11 Sep 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
103,986
-32%
50,000
$78.78
$3,938,842.00
SELL
10 Sep 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-6%
5,000
$76.63
$383,150.00
SELL
9 Sep 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
92,888
-34%
50,000
$78.19
$3,909,381.50
SELL
3 Sep 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
91,156
-63%
158,440
$87.87
$13,922,589.00
SELL
30 Aug 2019
PHILLIPS CHARLES G III
Director
NovoCure Ltd
(NVCR)
22,812
-49%
22,000
$91.14
$2,005,117.80
SELL
29 Aug 2019
VERNON W ANTHONY
Director
NovoCure Ltd
(NVCR)
158,589
-38%
100,000
$91.03
$9,103,100.00
SELL
29 Aug 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
200,869
-38%
124,181
$91.13
$11,316,198.00
SELL
12 Aug 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-6%
5,000
$86.45
$432,250.00
SELL
2 Aug 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
76,976
-2%
1,813
$85.23
$154,522.00
SELL
31 Jul 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
78,789
-8%
7,020
$83.00
$582,637.50
SELL
26 Jul 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
88,898
-12%
12,500
$77.94
$974,208.25
SELL
18 Jul 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
76,976
-8%
7,500
$70.00
$525,000.00
SELL
10 Jul 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-6%
5,000
$64.83
$324,155.00
SELL
28 Jun 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
258,311
-42%
187,500
$62.15
$11,653,125.00
SELL
27 Jun 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
65,037
-14%
11,175
$60.30
$673,852.50
SELL
24 Jun 2019
Donna Shalala
Congressman (House)
NovoCure Ltd
(NVCR)
N/A
N/A
N/A
$1,001 - $15,000
SELL
19 Jun 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
76,212
-14%
12,500
$60.00
$750,000.00
SELL
19 Jun 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
258,311
-8%
25,000
$61.46
$1,536,500.00
SELL
19 Jun 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,674
-37%
110,868
$60.00
$6,652,080.00
SELL
19 Jun 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,504
-26%
25,000
$60.02
$1,500,500.00
BUY
19 Jun 2019
Donna Shalala
Congressman (House)
NovoCure Ltd
(NVCR)
N/A
N/A
N/A
$1,001 - $15,000
SELL
18 Jun 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
258,311
-42%
190,338
$59.37
$11,300,367.00
SELL
11 Jun 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
276,514
-14%
47,271
$55.16
$2,607,615.20
SELL
10 Jun 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
76,272
-1%
1,130
$55.05
$62,211.68
SELL
10 Jun 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
69,604
-6%
5,000
$55.05
$275,265.80
SELL
6 Jun 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,674
-3%
5,999
$54.79
$328,661.22
SELL
5 Jun 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,674
-8%
17,500
$54.14
$947,485.00
SELL
3 Jun 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,874
-15%
35,000
$52.62
$1,841,741.00
SELL
30 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
846,463
-5%
48,100
$53.07
$2,552,522.80
SELL
29 May 2019
PHILLIPS CHARLES G III
Director
NovoCure Ltd
(NVCR)
12,424
-88%
95,100
$52.17
$4,961,198.00
SELL
29 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
894,563
-0%
1,900
$53.10
$100,880.50
SELL
10 May 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$49.79
$248,950.00
SELL
8 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
896,463
-3%
31,460
$47.37
$1,490,386.00
SELL
7 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
869,155
-6%
64,316
$47.60
$3,061,143.20
SELL
6 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
815,935
-3%
29,038
$48.07
$1,395,914.80
SELL
2 May 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
786,205
-3%
29,966
$45.21
$1,354,643.00
SELL
1 May 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
77,342
-1%
1,204
$43.80
$52,729.18
SELL
10 Apr 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$45.95
$229,750.00
SELL
1 Apr 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
185,806
-21%
49,891
$47.34
$2,362,053.00
SELL
11 Mar 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$48.31
$241,550.00
SELL
4 Mar 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
66,264
-57%
90,000
$53.94
$4,854,312.00
SELL
4 Mar 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
246,325
-6%
16,268
$55.89
$909,286.06
SELL
1 Mar 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
28,551
-58%
40,586
$55.63
$2,257,697.50
SELL
1 Mar 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
296,475
-25%
100,000
$55.57
$5,556,582.50
SELL
1 Mar 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-29%
25,000
$55.01
$1,375,275.00
SELL
27 Feb 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
25,239
-5%
1,558
$53.68
$83,633.44
SELL
27 Feb 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
66,264
-4%
3,288
$53.68
$176,499.84
SELL
27 Feb 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
36,835
-6%
2,368
$53.68
$127,114.24
SELL
27 Feb 2019
DOYLE WILLIAM F
Executive Chairman, Director, Officer
NovoCure Ltd
(NVCR)
918,306
-0%
3,097
$53.68
$166,246.97
SELL
27 Feb 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
233,757
-0%
903
$54.40
$49,118.68
SELL
27 Feb 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
169,305
-1%
2,397
$53.68
$128,670.96
SELL
22 Feb 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
23,710
-21%
6,377
$53.63
$341,985.75
SELL
22 Feb 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
61,835
-23%
18,647
$53.63
$1,000,001.30
SELL
22 Feb 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
33,647
-21%
9,325
$53.63
$500,081.10
SELL
22 Feb 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
165,528
-6%
12,230
$53.63
$655,870.44
SELL
12 Feb 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
171,164
-22%
50,000
$51.46
$2,573,000.00
SELL
11 Feb 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$49.59
$247,950.00
SELL
1 Feb 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
146,558
-28%
58,500
$49.21
$2,878,847.00
SELL
25 Jan 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,149
-48%
35,000
$49.20
$1,722,000.00
SELL
25 Jan 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-25%
20,000
$50.00
$1,000,000.00
SELL
24 Jan 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
21,305
-55%
26,874
$49.03
$1,317,731.10
SELL
23 Jan 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,149
-48%
35,000
$47.35
$1,657,250.00
SELL
23 Jan 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
171,164
-34%
88,695
$47.48
$4,211,238.50
SELL
18 Jan 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,149
-44%
30,000
$45.90
$1,376,910.00
SELL
18 Jan 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
184,808
-20%
46,863
$45.91
$2,151,356.50
SELL
16 Jan 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
17,087
-59%
25,000
$45.00
$1,125,075.00
SELL
16 Jan 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
21,305
-41%
15,000
$45.15
$677,250.00
SELL
16 Jan 2019
Kirson Eilon D.
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
109,063
-60%
168,813
$45.17
$7,624,788.00
SELL
16 Jan 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
171,164
-53%
200,000
$45.16
$9,031,704.00
SELL
16 Jan 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-25%
20,000
$45.00
$900,059.94
SELL
15 Jan 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,149
-44%
30,000
$44.20
$1,326,000.00
SELL
14 Jan 2019
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
171,164
-53%
200,000
$43.51
$8,701,200.00
SELL
11 Jan 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
17,087
-60%
26,251
$42.00
$1,102,647.00
SELL
10 Jan 2019
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,149
-44%
30,000
$42.35
$1,270,500.00
SELL
10 Jan 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
180,608
-23%
54,930
$40.88
$2,245,809.80
SELL
10 Jan 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$39.91
$199,550.00
SELL
9 Jan 2019
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
20,110
-30%
8,988
$40.00
$359,550.22
SELL
9 Jan 2019
Longsworth Todd Christopher
General Counsel, Officer
NovoCure Ltd
(NVCR)
21,305
-41%
15,000
$40.15
$602,250.00
SELL
9 Jan 2019
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
146,558
-40%
100,000
$40.00
$4,000,000.00
SELL
9 Jan 2019
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
66,726
-23%
20,000
$40.00
$800,067.25
SELL
12 Dec 2018
Shah Pritesh
Chief Commercial Officer, Officer
NovoCure Ltd
(NVCR)
18,237
-68%
38,781
$36.00
$1,396,135.80
SELL
28 Aug 2018
Palti Yoram
Chief Technology Officer, Director, Officer
NovoCure Ltd
(NVCR)
1,041,054
-0%
4,334
$40.27
$174,548.81
SELL
24 Aug 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
37,124
-48%
35,547
$40.01
$1,422,173.20
SELL
24 Aug 2018
Palti Yoram
Chief Technology Officer, Director, Officer
NovoCure Ltd
(NVCR)
1,045,388
-2%
25,666
$40.03
$1,027,308.00
SELL
22 Aug 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
72,671
-30%
31,179
$37.67
$1,174,603.40
SELL
14 Aug 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
108,118
-3%
4,368
$37.62
$164,345.40
SELL
2 Aug 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
110,008
-6%
7,126
$35.01
$249,499.50
SELL
1 Aug 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
115,644
-1%
1,241
$35.01
$43,445.00
SELL
27 Jul 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
NovoCure Ltd
(NVCR)
175,602
-26%
62,727
$35.08
$2,200,334.80
SELL
2 Jul 2018
Ambrogi Michael J.
Chief Operating Officer, Officer
NovoCure Ltd
(NVCR)
146,558
-28%
57,390
$31.48
$1,806,637.10
SELL
27 Jun 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
69,318
-50%
70,364
$32.09
$2,257,699.20
SELL
19 Jun 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
139,682
-6%
8,929
$32.03
$286,019.60
SELL
18 Jun 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
148,611
-13%
22,289
$32.00
$713,248.00
SELL
15 Jun 2018
Palti Yoram
Chief Technology Officer, Director, Officer
NovoCure Ltd
(NVCR)
1,101,054
-2%
30,000
$31.09
$932,802.00
SELL
14 Jun 2018
Palti Yoram
Chief Technology Officer, Director, Officer
NovoCure Ltd
(NVCR)
1,131,054
-2%
30,000
$31.64
$949,269.00
SELL
13 Jun 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
170,900
-6%
11,920
$32.00
$381,440.00
SELL
4 Jun 2018
Kirson Eilon D.
Chief Science Officer, Officer
NovoCure Ltd
(NVCR)
33,067
-91%
346,161
$28.90
$10,003,514.00
SELL
4 Jun 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
NovoCure Ltd
(NVCR)
260,246
-46%
227,304
$29.09
$6,612,801.00
SELL
15 May 2018
LEUNG GABRIEL
Director
Novocure Ltd
(NVCR)
60,000
-57%
80,000
$28.83
$2,306,000.00
SELL
11 May 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
Novocure Ltd
(NVCR)
189,190
-13%
30,470
$30.04
$915,268.00
SELL
1 May 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
Novocure Ltd
(NVCR)
208,591
-12%
30,470
$27.58
$840,362.60
SELL
1 May 2018
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
146,558
-29%
60,000
$27.40
$1,644,000.00
SELL
26 Apr 2018
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
152,986
-11%
20,000
$26.01
$520,141.90
SELL
26 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,175,820
-1%
20,966
$26.09
$547,012.75
SELL
23 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,182,020
-2%
35,600
$25.06
$892,281.75
SELL
19 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,217,620
-3%
49,362
$24.98
$1,233,224.50
SELL
18 Apr 2018
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
39,582
-78%
147,825
$24.00
$3,547,800.00
SELL
17 Apr 2018
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
146,558
-21%
40,000
$23.03
$921,240.00
SELL
17 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,266,982
-3%
44,072
$23.65
$1,042,304.30
SELL
4 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,311,054
-2%
30,000
$19.89
$596,754.00
SELL
2 Apr 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,367,354
-4%
60,000
$20.32
$1,219,428.80
SELL
29 Mar 2018
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,405,354
-2%
30,000
$21.67
$649,977.00
SELL
22 Feb 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
Novocure Ltd
(NVCR)
239,061
-5%
13,351
$19.83
$264,723.62
SELL
22 Feb 2018
Longsworth Todd Christopher
General Counsel, Officer
Novocure Ltd
(NVCR)
20,074
-24%
6,591
$19.83
$130,686.34
SELL
22 Feb 2018
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
96,830
-8%
8,458
$19.83
$167,705.22
SELL
29 Jan 2018
Longsworth Todd Christopher
General Counsel, Officer
Novocure Ltd
(NVCR)
4,998
-69%
11,630
$24.00
$279,120.00
SELL
29 Jan 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
356,790
-3%
13,974
$24.02
$335,588.40
SELL
25 Jan 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
370,764
-1%
6,456
$22.43
$144,839.72
SELL
23 Jan 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
377,220
-5%
20,848
$22.10
$460,801.50
SELL
16 Jan 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
398,068
-3%
14,900
$22.20
$330,754.66
SELL
11 Jan 2018
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
3,181
-88%
25,320
$22.00
$557,126.10
SELL
11 Jan 2018
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
412,968
-44%
336,420
$22.33
$7,511,740.50
SELL
8 Jan 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
Novocure Ltd
(NVCR)
209,078
-12%
31,132
$21.02
$654,375.94
SELL
3 Jan 2018
GROENHUYSEN WILHELMUS CM
Chief Financial Officer, Officer
Novocure Ltd
(NVCR)
239,900
-10%
28,868
$21.03
$607,002.56
SELL
10 Dec 2017
LEUNG GABRIEL
Director
NovoCure Ltd
(NVCR)
60,000
-7%
5,000
$33.49
$167,450.02
SELL
13 Nov 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,431,054
-2%
30,000
$17.13
$513,870.00
SELL
8 Nov 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,464,954
-5%
90,000
$18.49
$1,663,831.60
SELL
6 Nov 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
28,501
-24%
9,100
$22.00
$200,200.00
SELL
6 Nov 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
749,105
-0%
6,919
$22.00
$152,218.00
SELL
6 Nov 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,553,954
-3%
60,000
$21.06
$1,263,760.00
SELL
3 Nov 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
756,024
-0%
2,300
$22.00
$50,600.00
SELL
2 Nov 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
37,601
-8%
3,400
$22.00
$74,800.00
SELL
2 Nov 2017
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
24,087
-4%
1,200
$22.00
$26,400.00
SELL
2 Nov 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
1,611,054
-3%
60,000
$21.72
$1,303,200.00
SELL
31 Oct 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
41,001
-35%
22,269
$22.01
$490,110.44
SELL
31 Oct 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
758,324
-2%
15,866
$22.01
$349,169.88
SELL
31 Oct 2017
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
25,287
-49%
24,327
$22.01
$535,363.56
SELL
25 Sep 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
774,190
-0%
900
$22.05
$19,845.00
SELL
13 Sep 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
775,090
-4%
37,272
$22.01
$820,502.30
SELL
11 Jul 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
462,765
-1%
7,383
$19.95
$147,324.78
SELL
7 Jul 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
464,965
-37%
274,359
$18.07
$4,956,558.00
SELL
5 Jul 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
739,324
-17%
160,138
$18.14
$2,905,261.00
SELL
23 Jun 2017
Pomona Capital VII, L.P.
10% Owner
Novocure Ltd
(NVCR)
6,060,403
-15%
1,072,532
$17.35
$18,607,080.00
SELL
21 Jun 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
222,722
-22%
66,361
$16.78
$1,113,205.80
SELL
19 Jun 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
289,083
-4%
15,000
$15.06
$225,885.00
SELL
19 Jun 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
896,917
-12%
124,720
$15.51
$1,934,906.10
SELL
15 Jun 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
1,021,637
-3%
42,457
$15.15
$643,237.60
SELL
13 Jun 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
304,083
-2%
9,044
$15.01
$135,768.53
SELL
13 Jun 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
1,064,094
-8%
94,102
$15.22
$1,432,146.20
SELL
9 Jun 2017
Kirson Eilon D.
Chief Science Officer, Officer
Novocure Ltd
(NVCR)
313,127
-6%
20,956
$15.03
$315,053.38
SELL
9 Jun 2017
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
1,158,196
-13%
180,601
$15.13
$2,731,912.80
SELL
5 Jun 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
0
-100%
3,825
$13.82
$52,842.38
SELL
1 Jun 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
3,825
-67%
8,000
$13.27
$106,140.00
SELL
30 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
11,825
-40%
8,000
$12.49
$99,896.00
SELL
25 May 2017
PHILLIPS CHARLES G III
Director
NovoCure Ltd
(NVCR)
0
-100%
50,000
$30.30
$1,515,075.00
SELL
25 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
19,825
-28%
8,000
$12.88
$103,004.00
SELL
24 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
29,256
-12%
4,000
$13.15
$52,612.47
SELL
22 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
31,825
-20%
8,000
$11.73
$93,876.00
SELL
18 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
39,825
-16%
8,000
$11.39
$91,100.00
SELL
17 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
47,825
-7%
4,000
$11.47
$45,884.00
SELL
15 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
51,825
-13%
8,000
$12.05
$96,360.00
SELL
11 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
59,825
-11%
8,000
$11.79
$94,280.00
SELL
9 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
67,825
-10%
8,000
$12.29
$98,300.00
SELL
5 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
75,825
-9%
8,000
$11.82
$94,576.00
SELL
3 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
83,825
-8%
8,000
$11.42
$91,360.00
SELL
1 May 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
91,825
-8%
8,000
$11.64
$93,120.00
SELL
27 Apr 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
99,825
-7%
8,000
$11.25
$89,980.00
SELL
25 Apr 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
107,825
-6%
8,000
$10.78
$86,264.00
SELL
21 Apr 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
115,825
-6%
8,000
$11.26
$90,048.00
SELL
19 Apr 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
123,825
-6%
8,000
$11.24
$89,952.00
SELL
12 Apr 2017
Palti Yoram
Chief Technology Officer, Director, Officer
Novocure Ltd
(NVCR)
131,825
-10%
16,000
$10.64
$170,220.00
BUY
14 Mar 2017
Perlhagen Gert L.
Director
Novocure Ltd
(NVCR)
6,125,000
+2%
125,000
$6.93
$866,250.00
SELL
21 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
131,584
-17%
27,500
$8.27
$227,303.27
SELL
19 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
159,084
-20%
40,000
$8.69
$347,654.00
SELL
15 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
199,084
-16%
40,000
$8.93
$357,128.00
SELL
13 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
239,084
-14%
40,000
$8.97
$358,982.00
SELL
9 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
279,084
-5%
15,000
$9.01
$135,110.00
SELL
7 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
294,084
-3%
10,000
$8.30
$83,006.50
SELL
5 Dec 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
304,084
-3%
10,000
$8.24
$82,355.00
SELL
5 Aug 2016
Perlhagen Gert L.
Director, 10% Owner
Novocure Ltd
(NVCR)
566,576
-54%
676,576
$1.85
$1,252,030.60
SELL
8 Jun 2016
Ambrogi Michael J.
Chief Operating Officer, Officer
Novocure Ltd
(NVCR)
324,084
-5%
20,000
$12.24
$244,800.00
BUY
3 Mar 2016
Danziger Asaf
Chief Executive Officer, Director, Officer
Novocure Ltd
(NVCR)
933,557
+1%
10,000
$15.00
$150,000.00
BUY
3 Mar 2016
MYLOD ROBERT J JR
Director
Novocure Ltd
(NVCR)
20,000
+100%
20,000
$15.78
$315,600.00
Home